Opposite roles of Furin and PC5A in N-cadherin processing

Neoplasia (United States)

Volumn 14, Issue 10, 2012, Pages 880-892

  Maret, Deborah ^a   Sadr, Mohamad Seyed ^a   Sadr, Emad Seyed ^a   Colman, David R ^a   Del Maestro, Rolando F ^a   Seidah, Nabil G ^b  

^a MCGILL UNIVERSITY   (Canada)

^b CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

FURIN; MESSENGER RNA; NERVE CELL ADHESION MOLECULE; PROPROTEIN CONVERTASE 5; PROPROTEIN CONVERTASE 5A; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ARTICLE; CANCER INVASION; CELL ADHESION; CELL AGGREGATION; CELL MIGRATION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME LOCALIZATION; GLIOBLASTOMA; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOCYTOCHEMISTRY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PROCESSING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR GROWTH; WESTERN BLOTTING; WOUND HEALING;

EID: 84867804981     PISSN: 15228002     EISSN: 14765586     Source Type: Journal    
DOI: 10.1593/neo.121250     Document Type: Article

References (81)

1. Birchmeier W (1994). Molecular aspects of the loss of cell adhesion and gain of invasiveness in carcinomas. Princess Takamatsu Symp 24, 214-232.
2. Suyama K, Shapiro I, Guttman M, and Hazan RB (2002). A signaling pathway leading to metastasis is controlled by N-cadherin and the FGF receptor. Cancer Cell 2, 301-314.
3. Nieman MT, Prudoff RS, Johnson KR, and Wheelock MJ (1999). N-cadherin promotes motility in human breast cancer cells regardless of their E-cadherin expression. J Cell Biol 147, 631-644.
4. Ozawa M and Kemler R (1990). Correct proteolytic cleavage is required for the cell adhesive function of uvomorulin. J Cell Biol 111, 1645-1650.
5. Takeichi M (1988). The cadherins: cell-cell adhesion molecules controlling animal morphogenesis. Development 102, 639-655.
6. Christofori G (2006). New signals from the invasive front. Nature 441, 444-450.
7. Hsu MY, Meier FE, Nesbit M, Hsu JY, Van Belle BP, Elder DE, and Herlyn M (2000). E-cadherin expression in melanoma cells restores keratinocyte-mediated growth control and down-regulates expression of invasion-related adhesion receptors. Am J Pathol 156, 1515-1525.
8. Hazan RB, Qiao R, Keren R, Badano I, and Suyama K (2004). Cadherin switch in tumor progression. Ann N Y Acad Sci 1014, 155-163.
9. Frixen UH, Behrens J, Sachs M, Eberle G, Voss B, Warda A, Lochner D, and Birchmeier W (1991). E-cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells. J Cell Biol 113, 173-185.
10. Vleminckx K, Vakaet L Jr, Mareel M, Fiers W, and van Roy RF (1991). Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role. Cell 66, 107-119.
11. Takeichi M (1993). Cadherins in cancer: implications for invasion and metastasis. Curr Opin Cell Biol 5, 806-811.
12. Birchmeier W, Behrens J, Weidner KM, Frixen UH, and Schipper J (1991). Dominant and recessive genes involved in tumor cell invasion. Curr Opin Cell Biol 3, 832-840.
13. Perl AK, Wilgenbus P, Dahl U, Semb H, and Christofori G (1998). A causal role for E-cadherin in the transition from adenoma to carcinoma. Nature 392, 190-193.
14. Hirohashi S (1998). Inactivation of the E-cadherin-mediated cell adhesion system in human cancers. Am J Pathol 153, 333-339.
15. Christofori G and Semb H (1999). The role of the cell-adhesion molecule E-cadherin as a tumour-suppressor gene. Trends Biochem Sci 24, 73-76.
16. Islam S, Carey TE, Wolf GT, Wheelock MJ, and Johnson KR (1996). Expression of N-cadherin by human squamous carcinoma cells induces a scattered fibroblastic phenotype with disrupted cell-cell adhesion. J Cell Biol 135, 1643-1654.
17. Hazan RB, Kang L, Whooley BP, and Borgen PI (1997). N-cadherin promotes adhesion between invasive breast cancer cells and the stroma. Cell Adhes Commun 4, 399-411.
18. Hazan RB, Phillips GR, Qiao RF, Norton L, and Aaronson SA (2000). Exogenous expression of N-cadherin in breast cancer cells induces cell migration, invasion, and metastasis. J Cell Biol 148, 779-790.
19. Li G and Herlyn M (2000). Dynamics of intercellular communication during melanoma development. Mol Med Today 6, 163-169.
20. Asano K, Duntsch CD, Zhou Q, Weimar JD, Bordelon D, Robertson JH, and Pourmotabbed T (2004). Correlation of N-cadherin expression in high grade gliomas with tissue invasion. J Neurooncol 70, 3-15.
21. Koch AW, Farooq A, Shan W, Zeng L, Colman DR, and Zhou MM (2004). Structure of the neural (N-) cadherin prodomain reveals a cadherin extracellular domain-like fold without adhesive characteristics. Structure 12, 793-805.
22. Wahl JK III, Kim YJ, Cullen JM, Johnson KR, and Wheelock MJ (2003). N-cadherin-catenin complexes form prior to cleavage of the proregion and transport to the plasma membrane. J Biol Chem 278, 17269-17276.
23. Shore EM and Nelson WJ (1991). Biosynthesis of the cell adhesion molecule uvomorulin (E-cadherin) in Madin-Darby canine kidney epithelial cells. J Biol Chem 266, 19672-19680.
24. Seidah NG and Chretien M (1999). Proprotein and prohormone convertases: a family of subtilases generating diverse bioactive polypeptides. Brain Res 848, 45-62.
25. Seidah NG and Prat A (2012). The biology and therapeutic targeting of the proprotein convertases. Nat Rev Drug Discov 11, 367-383.
26. Thomas G (2002). Furin at the cutting edge: from protein traffic to embryogenesis and disease. Nat Rev Mol Cell Biol 3, 753-766.
27. Mayer G, Hamelin J, Asselin MC, Pasquato A, Marcinkiewicz E, Tang M, Tabibzadeh S, and Seidah NG (2008). The regulated cell surface zymogen activation of the proprotein convertase PC5A directs the processing of its secretory substrates. J Biol Chem 283, 2373-2384.
28. Rousselet E, Benjannet S, Marcinkiewicz E, Asselin MC, Lazure C, and Seidah NG (2011). Proprotein convertase PC7 enhances the activation of the EGF receptor pathway through processing of the EGF precursor. J Biol Chem 286, 9185-9195.
29. Maret D, Gruzglin E, Sadr MS, Siu V, Shan W, Koch AW, Seidah NG, Del Maestro RF, and Colman DR (2010). Surface expression of precursor N-cadherin promotes tumor cell invasion. Neoplasia 12, 1066-1080.
30. Posthaus H, Dubois CM, Laprise MH, Grondin F, Suter MM, and Muller E (1998). Proprotein cleavage of E-cadherin by furin in baculovirus over-expression system: potential role of other convertases in mammalian cells. FEBS Lett 438, 306-310.
31. Khatib AM, Siegfried G, Prat A, Luis J, Chretien M, Metrakos P, and Seidah NG (2001). Inhibition of proprotein convertases is associated with loss of growth and tumorigenicity of HT-29 human colon carcinoma cells: importance of insulin-like growth factor-1 (IGF-1) receptor processing in IGF-1-mediated functions. J Biol Chem 276, 30686-30693.
32. Khatib AM, Siegfried G, Chretien M, Metrakos P, and Seidah NG (2002). Proprotein convertases in tumor progression and malignancy: novel targets in cancer therapy. Am J Pathol 160, 1921-1935.
33. Bassi DE, Fu J, Lopez DC, and Klein-Szanto AJ (2005). Proprotein convertases: "master switches" in the regulation of tumor growth and progression. Mol Carcinog 44, 151-161.
34. Coppola JM, Bhojani MS, Ross BD, and Rehemtulla A (2008). A smallmolecule furin inhibitor inhibits cancer cell motility and invasiveness. Neoplasia 10, 363-370.
35. Bassi DE, Lopez DC, Mahloogi H, Zucker S, Thomas G, and Klein-Szanto AJ (2001). Furin inhibition results in absent or decreased invasiveness and tumorigenicity of human cancer cells. Proc Natl Acad Sci USA 98, 10326-10331.
36. D'Anjou F, Routhier S, Perreault JP, Latil A, Bonnel D, Fournier I, Salzet M, and Day R (2011). Molecular validation of PACE4 as a target in prostate cancer. Transl Oncol 4, 157-172.
37. Scamuffa N, Siegfried G, Bontemps Y, Ma L, Basak A, Cherel G, Calvo F, Seidah NG, and Khatib AM (2008). Selective inhibition of proprotein convertases represses the metastatic potential of human colorectal tumor cells. J Clin Invest 118, 352-363.
38. Bassi DE, Zhang J, Cenna J, Litwin S, Cukierman E, and Klein-Szanto AJ (2010). Proprotein convertase inhibition results in decreased skin cell proliferation, tumorigenesis, and metastasis. Neoplasia 12, 516-526.
39. Lapierre M, Siegfried G, Scamuffa N, Bontemps Y, Calvo F, Seidah NG, and Khatib AM (2007). Opposing function of the proprotein convertases furin and PACE4 on breast cancer cells' malignant phenotypes: role of tissue inhibitors of metalloproteinase-1. Cancer Res 67, 9030-9034.
40. Huang Y-H, Lin K-H, Liao CH, Lai M-W, Tseng Y-H, and Yeh C (2012). Furin overexpression suppresses tumor growth and predicts a better postoperative disease-free survival in hepatocellular carcinoma. PLoS One 7, e40738.
41. Sun X, Essalmani R, Seidah NG, and Prat A (2009). The proprotein convertase PC5/6 is protective against intestinal tumorigenesis: in vivo mouse model. Mol Cancer 8, 73.
42. Gumbiner BM (2005). Regulation of cadherin-mediated adhesion in morphogenesis. Nat Rev Mol Cell Biol 6, 622-634.
43. Matsunaga M, Hatta K, Nagafuchi A, and Takeichi M (1988). Guidance of optic nerve fibres by N-cadherin adhesion molecules. Nature 334, 62-64.
44. Kiryushko D, Berezin V, and Bock E (2004). Regulators of neurite outgrowth: role of cell adhesion molecules. Ann N Y Acad Sci 1014, 140-154.
45. Skaper SD (2005). Neuronal growth-promoting and inhibitory cues in neuroprotection and neuroregeneration. Ann N Y Acad Sci 1053, 376-385.
46. Hatta K and Takeichi M (1986). Expression of N-cadherin adhesion molecules associated with early morphogenetic events in chick development. Nature 320, 447-449.
47. Derycke LD and Bracke ME (2004). N-cadherin in the spotlight of cell-cell adhesion, differentiation, embryogenesis, invasion and signalling. Int J Dev Biol 48, 463-476.
48. Tucker RP (2004). Neural crest cells: a model for invasive behavior. Int J Biochem Cell Biol 36, 173-177.
49. Reines A, Bernier LP, McAdam R, Belkaid W, Shan W, Koch AW, Seguela P, Colman DR, and Dhaunchak AS (2012). N-cadherin prodomain processing regulates synaptogenesis. J Neurosci 32, 6323-6334.
50. Nour N, Mayer G, Mort JS, Salvas A, Mbikay M, Morrison CJ, Overall CM, and Seidah NG (2005). The cysteine-rich domain of the secreted proprotein convertases PC5A and PACE4 functions as a cell surface anchor and interacts with tissue inhibitors of metalloproteinases. Mol Biol Cell 16, 5215-5226.
51. Rousselet E, Benjannet S, Hamelin J, Canuel M, and Seidah NG (2011). The proprotein convertase PC7: unique zymogen activation and trafficking pathways. J Biol Chem 286, 2728-2738.
52. Essalmani R, Hamelin J, Marcinkiewicz J, Chamberland A, Mbikay M, Chretien M, Seidah NG, and Prat A (2006). Deletion of the gene encoding proprotein convertase 5/6 causes early embryonic lethality in the mouse. Mol Cell Biol 26, 354-361.
53. Siegfried G, Khatib AM, Benjannet S, Chretien M, and Seidah NG (2003). The proteolytic processing of pro-platelet-derived growth factor-A at RRKR86 by members of the proprotein convertase family is functionally correlated to plateletderived growth factor-A-induced functions and tumorigenicity. Cancer Res 63, 1458-1463.
54. Kacprzak MM, Peinado JR, Than ME, Appel J, Henrich S, Lipkind G, Houghten RA, Bode W, and Lindberg I (2004). Inhibition of furin by polyargininecontaining peptides: nanomolar inhibition by nona-D-arginine. J Biol Chem 279, 36788-36794.
55. Susan-Resiga D, Essalmani R, Hamelin J, Asselin MC, Benjannet S, Chamberland A, Day R, Szumska D, Constam D, Bhattacharya S, et al. (2011). Furin is the major processing enzyme of the cardiac-specific growth factor bone morphogenetic protein 10. J Biol Chem 286, 22785-22794.
56. Villeneuve P, Seidah NG, and Beaudet A (1999). Immunohistochemical distribution of the prohormone convertase PC5-A in rat brain. Neuroscience 92, 641-654.
57. Henrich S, Lindberg I, Bode W, and Than ME (2005). Proprotein convertase models based on the crystal structures of furin and kexin: explanation of their specificity. J Mol Biol 345, 211-227.
58. Henrich S, Cameron A, Bourenkov GP, Kiefersauer R, Huber R, Lindberg I, Bode W, and Than ME (2003). The crystal structure of the proprotein processing proteinase furin explains its stringent specificity. Nat Struct Biol 10, 520-526.
59. Komiyama T, VanderLugt B, Fugere M, Day R, Kaufman RJ, and Fuller RS (2003). Optimization of protease-inhibitor interactions by randomizing adventitious contacts. Proc Natl Acad Sci USA 100, 8205-8210.
60. Guo HB, Johnson H, Randolph M, and Pierce M (2009). Regulation of homotypic cell-cell adhesion by branched N-glycosylation of N-cadherin extracellular EC2 and EC3 domains. J Biol Chem 284, 34986-34997.
61. Gram Schjoldager KT, Vester-Christensen MB, Goth CK, Petersen TN, Brunak S, Bennett EP, Levery SB, and Clausen H (2011). A systematic study of site-specific GalNAc-type O-glycosylation modulating proprotein convertase processing. J Biol Chem 286, 40122-40132.
62. Leckband D and Prakasam A (2006). Mechanism and dynamics of cadherin adhesion. Annu Rev Biomed Eng 8, 259-287.
63. Harrison OJ, Bahna F, Katsamba PS, Jin X, Brasch J, Vendome J, Ahlsen G, Carroll KJ, Price SR, Honig B, et al. (2010). Two-step adhesive binding by classical cadherins. Nat Struct Mol Biol 17, 348-357.
64. Tanaka H, Shan W, Phillips GR, Arndt K, Bozdagi O, Shapiro L, Huntley GW, Benson DL, and Colman DR (2000). Molecular modification of N-cadherin in response to synaptic activity. Neuron 25, 93-107.
65. Ozawa M (2002). Lateral dimerization of the E-cadherin extracellular domain is necessary but not sufficient for adhesive activity. J Biol Chem 277, 19600-19608.
66. Shan W, Yagita Y, Wang Z, Koch A, Fex SA, Gruzglin E, Pedraza L, and Colman DR (2004). The minimal essential unit for cadherin-mediated intercellular adhesion comprises extracellular domains 1 and 2. J Biol Chem279, 55914-55923.
67. Boggon TJ, Murray J, Chappuis-Flament S, Wong E, Gumbiner BM, and Shapiro L (2002). C-cadherin ectodomain structure and implications for cell adhesion mechanisms. Science 296, 1308-1313.
68. Cui Y, Hackenmiller R, Berg L, Jean F, Nakayama T, Thomas G, and Christian JL (2001). The activity and signaling range of mature BMP-4 is regulated by sequential cleavage at two sites within the prodomain of the precursor. Genes Dev 15, 2797-2802.
69. Lopez DC, Bassi DE, Zucker S, Seidah NG, and Klein-Szanto AJ (2005). Human carcinoma cell growth and invasiveness is impaired by the propeptide of the ubiquitous proprotein convertase furin. Cancer Res 65, 4162-4171.
70. Mercapide J, Lopez DC, Bassi DE, Castresana JS, Thomas G, and Klein-Szanto AJ (2002). Inhibition of furin-mediated processing results in suppression of astrocytoma cell growth and invasiveness. Clin Cancer Res 8, 1740-1746.
71. Nejjari M, Berthet V, Rigot V, Laforest S, Jacquier MF, Seidah NG, Remy L, Bruyneel E, Scoazec JY, Marvaldi J, et al. (2004). Inhibition of proprotein convertases enhances cell migration and metastases development of human colon carcinoma cells in a rat model. Am J Pathol 164, 1925-1933.
72. Jin W, Fuki IV, Seidah NG, Benjannet S, Glick JM, and Rader DJ (2005). Proprotein convertases are responsible for proteolysis and inactivation of endothelial lipase. J Biol Chem 280, 36551-36559.
73. Thiery JP, Acloque H, Huang RY, and Nieto MA (2009). Epithelial-mesenchymal transitions in development and disease. Cell 139, 871-890.
74. Peinado H, Olmeda D, and Cano A (2007). Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype? Nat Rev Cancer 7, 415-428.
75. Qi J, Chen N, Wang J, and Siu CH (2005). Transendothelial migration of melanoma cells involves N-cadherin-mediated adhesion and activation of the beta-catenin signaling pathway. Mol Biol Cell 16, 4386-4397.
76. Tomita K, van Leenders BA, van Leenders GJ, Ruijter ET, Jansen CF, Bussemakers MJ, and Schalken JA (2000). Cadherin switching in human prostate cancer progression. Cancer Res 60, 3650-3654.
77. Li G, Satyamoorthy K, and Herlyn M (2001). N-cadherin-mediated intercellular interactions promote survival and migration of melanoma cells. Cancer Res 61, 3819-3825.
78. Bussemakers MJ, Van Bokhoven BA, Tomita K, Jansen CF, and Schalken JA (2000). Complex cadherin expression in human prostate cancer cells. Int J Cancer 85, 446-450.
79. Nakajima G, Patino-Garcia A, Bruheim S, Xi Y, San JM, Lecanda F, Sierrasesumaga L, Muller C, Fodstad O, and Ju J (2008). CDH11 expression is associated with survival in patients with osteosarcoma. Cancer Genomics Proteomics 5, 37-42.
80. Bigner DD, Brown MT, Friedman AH, Coleman RE, Akabani G, Friedman HS, Thorstad WL, McLendon RE, Bigner SH, Zhao XG, et al. (1998). Iodine-131-labeled antitenascin monoclonal antibody 81C6 treatment of patients with recurrent malignant gliomas: phase I trial results. J Clin Oncol 16, 2202-2212.
81. Burger PC (1990). Morphologic correlates in gliomas: where do we stand? Monogr Pathol 32, 16-29.